Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study comparing semaglutide and dapagliflozin taken separately or combined in one tablet for type 2 diabetes patients

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Study of oral and injectable NNC0487-0111 (Amycretin) to find the best dose for blood sugar control in adults with type 2 diabetes taking metformin with or without SGLT2 inhibitor

    Not recruiting

    2 1 1
    Investigated Diseases:
    Bulgaria Croatia Germany Greece Hungary Poland +3
  • Study comparing RO7795081 and semaglutide with placebo in adults with type 2 diabetes mellitus

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Hungary Poland Spain
  • Study of Orforglipron for Weight Management in People with Obesity or Overweight, With or Without Type 2 Diabetes

    Not recruiting

    3 1
    Czechia Germany
  • Study on Insulin Aspart for Recovery from Low Blood Sugar in People with and without Type 2 Diabetes

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria
  • Study on Personalized Treatment Using Dapagliflozin, Dulaglutide, and Metformin for Patients with Uncontrolled Type 2 Diabetes

    Not recruiting

    3 1 1 1
    Spain
  • Study on the Effectiveness of Survodutide for Weight Loss in Patients with Type 2 Diabetes and Obesity

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia Denmark Finland Germany Greece +5
  • Study on Preventing Heart Disease in Diabetes Patients Using Eprosartan Mesilate and Drug Combination

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Austria Spain
  • Study of NNC0519-0130 and semaglutide in people with chronic kidney disease who are overweight or obese, with or without type 2 diabetes

    Not recruiting

    2 1 1
    Investigated Drugs:
    Bulgaria Italy Poland Spain
  • Study on the Safety and Effectiveness of Utreglutide (GL0034) for Adults with Type 2 Diabetes Not Well Managed with Metformin or Lifestyle Changes

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Germany